Skip to main content

Table 4 Correlation between metabolic phenotypes of tumor and clinicopathologic factors

From: Metabolic phenotypes in primary unknown metastatic carcinoma

Parameters

Glycolysis type

Glutaminolysis type

Mitochondrial type

Yes

No

p-value

Yes

No

p-value

Yes

No

p-value

n = 33 (%)

n = 44 (%)

 

n = 43 (%)

n = 34 (%)

 

n = 74 (%)

n = 3 (%)

Age

  

0.087

  

0.340

  

1.000

 <50

7 (21.2)

18 (40.9)

 

16 (37.2)

9 (26.5)

 

24 (32.4)

1 (33.3)

 

 ≥50

26 (78.8)

26 (59.1)

 

27 (62.8)

25 (73.5)

 

50 (67.6)

2 (66.7)

 

Sex

  

0.342

  

1.000

  

1.000

 Male

23 (69.7)

25 (56.8)

 

27 (62.8)

21 (61.8)

 

46 (62.2)

2 (66.7)

 

 Female

10 (30.3)

19 (43.2)

 

16 (37.2)

13 (38.2)

 

28 (37.8)

1 (33.3)

 

Clinical subtype

  

0.371

  

0.971

  

0.687

 Nodal type

18 (54.5)

16 (36.4)

 

18 (41.9)

16 (47.1)

 

33 (44.6)

1 (33.3)

 

 Single organ type

5 (15.2)

10 (22.7)

 

9 (20.9)

6 (17.6)

 

15 (20.3)

0 (0.0)

 

 Intermediate type

6 (18.2)

8 (18.2)

 

8 (18.6)

6 (17.6)

 

13 (17.6)

1 (33.3)

 

 Carcinomatosis type

4 (12.1)

10 (22.7)

 

8 (18.6)

6 (17.6)

 

13 (17.6)

1 (33.3)

 

Histologic type

  

0.093

  

0.545

  

0.208

 AD

11 (33.3)

16 (36.4)

 

17 (39.5)

10 (29.4)

 

26 (35.1)

1 (33.3)

 

 PD

4 (12.1)

12 (27.3)

 

8 (18.6)

8 (23.5)

 

14 (18.9)

2 (66.7)

 

 SQ

13 (39.4)

7 (15.9)

 

9 (20.9)

11 (32.4)

 

20 (27.0)

0 (0.0)

 

 UP

5 (15.2)

9 (20.5)

 

9 (20.9)

5 (14.7)

 

14 (18.9)

0 (0.0)

 

Organs involved

  

0.392

  

0.730

  

0.026

 Lymph node

24 (72.7)

25 (56.8)

 

27 (62.8)

22 (64.7)

 

48 (64.9)

1 (33.3)

 

 Bone

3 (9.1)

7 (15.9)

 

7 (16.3)

3 (8.8)

 

10 (13.5)

0 (0.0)

 

 Brain

4 (12.1)

5 (11.4)

 

4 (9.3)

5 (14.7)

 

9 (12.2)

0 (0.0)

 

 Other

2 (6.1)

7 (15.9)

 

5 (11.6)

4 (11.8)

 

7 (9.5)

2 (66.7)

 
  1. Bold represents p<0.05.